candesartan has been researched along with Cerebrovascular Disorders in 5 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
Excerpt | Relevance | Reference |
---|---|---|
"Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats." | 7.76 | Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. ( Culman, J; Hocher, B; Mueller, S; Muller, DN; Pfab, T; Schmerbach, K; Thoene-Reineke, C; Unger, T; Villringer, A; Zhao, Y, 2010) |
"Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats." | 3.76 | Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. ( Culman, J; Hocher, B; Mueller, S; Muller, DN; Pfab, T; Schmerbach, K; Thoene-Reineke, C; Unger, T; Villringer, A; Zhao, Y, 2010) |
"Diabetes and hypertension are potent risk factors for cerebrovascular disease." | 1.33 | Diabetic brain damage in hypertension: role of renin-angiotensin system. ( Eguchi, K; Hoshide, S; Ishikawa, J; Ishikawa, S; Kario, K; Matsui, Y; Morinari, M; Shimada, K, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schmerbach, K | 1 |
Pfab, T | 1 |
Zhao, Y | 1 |
Culman, J | 1 |
Mueller, S | 1 |
Villringer, A | 1 |
Muller, DN | 1 |
Hocher, B | 1 |
Unger, T | 1 |
Thoene-Reineke, C | 1 |
Kario, K | 1 |
Ishikawa, J | 1 |
Hoshide, S | 1 |
Matsui, Y | 1 |
Morinari, M | 1 |
Eguchi, K | 1 |
Ishikawa, S | 1 |
Shimada, K | 1 |
Nakamura, T | 1 |
Honma, H | 1 |
Ikeda, Y | 1 |
Kuroyanagi, R | 1 |
Takano, H | 1 |
Obata, J | 1 |
Sato, T | 1 |
Kimura, H | 1 |
Yoshida, Y | 1 |
Tamura, K | 1 |
Bennai, F | 1 |
Morsing, P | 1 |
Paliege, A | 1 |
Ketteler, M | 1 |
Mayer, B | 1 |
Tapp, R | 1 |
Bachmann, S | 1 |
Saavedra, JM | 1 |
Nishimura, Y | 1 |
1 review available for candesartan and Cerebrovascular Disorders
Article | Year |
---|---|
Angiotensin and cerebral blood flow.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimid | 1999 |
4 other studies available for candesartan and Cerebrovascular Disorders
Article | Year |
---|---|
Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes.
Topics: Amides; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzimidaz | 2010 |
Diabetic brain damage in hypertension: role of renin-angiotensin system.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspartic Acid; Benzimidazoles; Biphenyl Compounds; Bl | 2005 |
Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cereb | 1994 |
Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Arterioles; Benzimidazoles; Biphenyl Compounds; Blood Pre | 1999 |